ProShares UltraShort Bloomberg Natrl Gas

Direxion Daily Small Cap Bear 3X ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Direxion Daily Technology Bull 3X ETF

Direxion Daily Semicondct Bull 3X ETF

ProShares Ultra Silver

Direxion Daily S&P Biotech Bear 3X ETF

Bank Of Montreal

ProShares Bitcoin Strategy ETF

Deutsche X-trackers Harvest CSI300 CHN A

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Small Cap Bull 3X ETF

Direxion Dly S&P Oil&Gs Ex&Prd Bl 3X ETF

VS TR 2x Long VIX Futures ETF

Real Estate Select Sector SPDR

Direxion Daily Semicondct Bear 3X ETF

United States Natural Gas

Direxion Technology Bear 3X Shares

ProShares UltraShort Silver

QuantumScape Corporation Class A Common Stock

AgEagle Aerial Systems Inc. Common Stock

Dick's Sporting Goods Inc Common Stock

Kennametal Inc. Common Stock

ICL Group Ltd. Ordinary Shares

Endeavour Silver Corporation Ordinary Shares (Canada)

Cloudflare Inc. Class A Common Stock

Affiliated Managers Group Inc. Common Stock

Alamos Gold Inc. Class A Common Shares

The AZEK Company Inc. Class A Common Stock

Winnebago Industries Inc. Common Stock

Oklo Inc.

Primerica Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

Boston Properties Inc. Common Stock

Civitas Resources Inc. Common Stock

Gates Industrial Corporation plc Ordinary Shares

XPeng Inc. American depositary shares each representing two Class A ordinary shares

EQT Corporation Common Stock

Granite Point Mortgage Trust Inc. Common Stock

Click here to get full coverage on Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now - Nasdaq

Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now  Nasdaq

Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now - Nasdaq

Click here to get full coverage on P3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance

P3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look For  Yahoo Finance

P3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Click here to get full coverage on P3 Health Partners Inc. (PIII) reports earnings - Quartz

P3 Health Partners Inc. (PIII) reports earnings  Quartz

P3 Health Partners Inc. (PIII) reports earnings - Quartz

Click here to get full coverage on P3 Health Partners Eyes Profitability: Unveils Ambitious $1.5B Revenue Target for 2025 - Stock Titan

P3 Health Partners Eyes Profitability: Unveils Ambitious $1.5B Revenue Target for 2025  Stock Titan

P3 Health Partners Eyes Profitability: Unveils Ambitious $1.5B Revenue Target for 2025 - Stock Titan

Click here to get full coverage on P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference  Business Wire

P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

Click here to get full coverage on PIII stock touches 52-week low at $6.86 amid market challenges - Investing.com

PIII stock touches 52-week low at $6.86 amid market challenges  Investing.com

PIII stock touches 52-week low at $6.86 amid market challenges - Investing.com

Click here to get full coverage on -Heteroatom-Templated Tetrahedral Heteropolyoxometalate Cluster for Detecting Early Tumor Marker MicroRNA-155 - ACS Publications

-Heteroatom-Templated Tetrahedral Heteropolyoxometalate Cluster for Detecting Early Tumor Marker MicroRNA-155  ACS Publications

-Heteroatom-Templated Tetrahedral Heteropolyoxometalate Cluster for Detecting Early Tumor Marker MicroRNA-155 - ACS Publications

Click here to get full coverage on Sb‐to‐P Metathesis: A Direct Route to Structurally Constrained, Cationic PIII Compound - Wiley Online Library

Sb‐to‐P Metathesis: A Direct Route to Structurally Constrained, Cationic PIII Compound  Wiley Online Library

Sb‐to‐P Metathesis: A Direct Route to Structurally Constrained, Cationic PIII Compound - Wiley Online Library

Click here to get full coverage on P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27 - Business Wire

P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27  Business Wire

P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27 - Business Wire

Click here to get full coverage on P3 Health Partners Announces 1-for-50 Reverse Stock Split - Investing.com

P3 Health Partners Announces 1-for-50 Reverse Stock Split  Investing.com

P3 Health Partners Announces 1-for-50 Reverse Stock Split - Investing.com

Click here to get full coverage on Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII) - Nasdaq

Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)  Nasdaq

Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII) - Nasdaq

Click here to get full coverage on PIII/PV═O Redox Catalysis Mediated Thioesterification of Carboxylic Acids with Disulfides under Air Conditions - ACS Publications

PIII/PV═O Redox Catalysis Mediated Thioesterification of Carboxylic Acids with Disulfides under Air Conditions  ACS Publications

PIII/PV═O Redox Catalysis Mediated Thioesterification of Carboxylic Acids with Disulfides under Air Conditions - ACS Publications

Click here to get full coverage on P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference - Business Wire

P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference  Business Wire

P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference - Business Wire

Click here to get full coverage on P3 Health Partners Inc.'s (NASDAQ:PIII) market cap dropped US$9.5m last week; Private equity firms bore the brunt - Yahoo Finance

P3 Health Partners Inc.'s (NASDAQ:PIII) market cap dropped US$9.5m last week; Private equity firms bore the brunt  Yahoo Finance

P3 Health Partners Inc.'s (NASDAQ:PIII) market cap dropped US$9.5m last week; Private equity firms bore the brunt - Yahoo Finance

Click here to get full coverage on P3 Health Partners Announces Third Quarter 2024 Results - Business Wire

P3 Health Partners Announces Third Quarter 2024 Results  Business Wire

P3 Health Partners Announces Third Quarter 2024 Results - Business Wire

Click here to get full coverage on P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance

P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results - Business Wire

P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results  Business Wire

P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results - Business Wire

Click here to get full coverage on P3 Health Partners Inc. Faces Nasdaq Delisting Risk Amid Bid Price Compliance Struggles - Nasdaq

P3 Health Partners Inc. Faces Nasdaq Delisting Risk Amid Bid Price Compliance Struggles  Nasdaq

P3 Health Partners Inc. Faces Nasdaq Delisting Risk Amid Bid Price Compliance Struggles - Nasdaq

Click here to get full coverage on Figure 7 PIII treatment promotes HUVEC adhesion on tubular electrospun... - researchgate.net

Figure 7 PIII treatment promotes HUVEC adhesion on tubular electrospun...  researchgate.net

Figure 7 PIII treatment promotes HUVEC adhesion on tubular electrospun... - researchgate.net

Click here to get full coverage on Figure 4 rDV and PIII treatment enhanced HUVEC cell-cell interactions... - researchgate.net

Figure 4 rDV and PIII treatment enhanced HUVEC cell-cell interactions...  researchgate.net

Figure 4 rDV and PIII treatment enhanced HUVEC cell-cell interactions... - researchgate.net

Click here to get full coverage on Figure 8 rDV enhances HUVEC retention on PIII treated tubular... - researchgate.net

Figure 8 rDV enhances HUVEC retention on PIII treated tubular...  researchgate.net

Figure 8 rDV enhances HUVEC retention on PIII treated tubular... - researchgate.net

Click here to get full coverage on P3 Health Partners approves reverse stock split - Investing.com

P3 Health Partners approves reverse stock split  Investing.com

P3 Health Partners approves reverse stock split - Investing.com

Click here to get full coverage on P3 Health Partners Announces First Quarter 2025 Results - Business Wire

P3 Health Partners Announces First Quarter 2025 Results  Business Wire

P3 Health Partners Announces First Quarter 2025 Results - Business Wire

Click here to get full coverage on Synthesis of C(3) SCF3-Substituted Pyrrolidinoindoline by PIII/PV Redox Catalysis Using CF3SO2Cl as Electrophilic CF3S Reagent - ACS Publications

Synthesis of C(3) SCF3-Substituted Pyrrolidinoindoline by PIII/PV Redox Catalysis Using CF3SO2Cl as Electrophilic CF3S Reagent  ACS Publications

Synthesis of C(3) SCF3-Substituted Pyrrolidinoindoline by PIII/PV Redox Catalysis Using CF3SO2Cl as Electrophilic CF3S Reagent - ACS Publications

Click here to get full coverage on Upcoming Stock Splits This Week (April 14 to April 18) – Stay Invested - The Globe and Mail

Upcoming Stock Splits This Week (April 14 to April 18) – Stay Invested  The Globe and Mail

Upcoming Stock Splits This Week (April 14 to April 18) – Stay Invested - The Globe and Mail

Click here to get full coverage on P3 Health Partners’ Shareholders Approve Key Proposals - TipRanks

P3 Health Partners’ Shareholders Approve Key Proposals  TipRanks

P3 Health Partners’ Shareholders Approve Key Proposals - TipRanks

Click here to get full coverage on P3 Health Partners Secures $70M Financing Deal - TipRanks

P3 Health Partners Secures $70M Financing Deal  TipRanks

P3 Health Partners Secures $70M Financing Deal - TipRanks

Click here to get full coverage on Fig. 3. Identification of oxygen vacancies in the Zr & O PIII sample:... - researchgate.net

Fig. 3. Identification of oxygen vacancies in the Zr & O PIII sample:...  researchgate.net

Fig. 3. Identification of oxygen vacancies in the Zr & O PIII sample:... - researchgate.net

Click here to get full coverage on P3 Health Partners secures $25 million financing deal - Investing.com

P3 Health Partners secures $25 million financing deal  Investing.com

P3 Health Partners secures $25 million financing deal - Investing.com

Click here to get full coverage on Identified peptide sequences exposed on the pIII protein of the M13... - researchgate.net

Identified peptide sequences exposed on the pIII protein of the M13...  researchgate.net

Identified peptide sequences exposed on the pIII protein of the M13... - researchgate.net

Click here to get full coverage on Electrophilic C(sp2)−H Cyanation with Inorganic Cyanate (OCN−) by PIII/PV=O‐Catalyzed Phase Transfer Activation - Wiley Online Library

Electrophilic C(sp2)−H Cyanation with Inorganic Cyanate (OCN−) by PIII/PV=O‐Catalyzed Phase Transfer Activation  Wiley Online Library

Electrophilic C(sp2)−H Cyanation with Inorganic Cyanate (OCN−) by PIII/PV=O‐Catalyzed Phase Transfer Activation - Wiley Online Library

Click here to get full coverage on P3 Health Partners (PIII) Stock Price, News & Analysis - MarketBeat

P3 Health Partners (PIII) Stock Price, News & Analysis  MarketBeat

P3 Health Partners (PIII) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Atroposelective Arene‐Forming Wittig Reaction by Phosphorus PIII/PV=O Redox Catalysis - Wiley Online Library

Atroposelective Arene‐Forming Wittig Reaction by Phosphorus PIII/PV=O Redox Catalysis  Wiley Online Library

Atroposelective Arene‐Forming Wittig Reaction by Phosphorus PIII/PV=O Redox Catalysis - Wiley Online Library

Click here to get full coverage on PIII News Today | Why did P3 Health Partners stock go up today? - MarketBeat

PIII News Today | Why did P3 Health Partners stock go up today?  MarketBeat

PIII News Today | Why did P3 Health Partners stock go up today? - MarketBeat

Click here to get full coverage on Coupling of Chlorophosphines with Organic Halides: Photoinduced P - Wiley Online Library

Coupling of Chlorophosphines with Organic Halides: Photoinduced P  Wiley Online Library

Coupling of Chlorophosphines with Organic Halides: Photoinduced P - Wiley Online Library

Click here to get full coverage on Upgrading Carbazolyl-Derived Phosphine Ligands Using Rh - ACS Publications

Upgrading Carbazolyl-Derived Phosphine Ligands Using Rh  ACS Publications

Upgrading Carbazolyl-Derived Phosphine Ligands Using Rh - ACS Publications

Click here to get full coverage on ═O-Catalysis: Synthetic Capture of the Transient Nef Intermediate HNO - ACS Publications

═O-Catalysis: Synthetic Capture of the Transient Nef Intermediate HNO  ACS Publications

═O-Catalysis: Synthetic Capture of the Transient Nef Intermediate HNO - ACS Publications

Click here to get full coverage on P3 Health Partners Inc. Announces Approximately $42.2 Million Private Placement - Business Wire

P3 Health Partners Inc. Announces Approximately $42.2 Million Private Placement  Business Wire

P3 Health Partners Inc. Announces Approximately $42.2 Million Private Placement - Business Wire

Click here to get full coverage on Atroposelective PIII/PV=O Redox Catalysis for the Isoquinoline‐Forming Staudinger–aza‐Wittig Reaction - Wiley Online Library

Atroposelective PIII/PV=O Redox Catalysis for the Isoquinoline‐Forming Staudinger–aza‐Wittig Reaction  Wiley Online Library

Atroposelective PIII/PV=O Redox Catalysis for the Isoquinoline‐Forming Staudinger–aza‐Wittig Reaction - Wiley Online Library

Click here to get full coverage on Chicago Pacific Founders buys P3 Health shares worth over $81k - Investing.com

Chicago Pacific Founders buys P3 Health shares worth over $81k  Investing.com

Chicago Pacific Founders buys P3 Health shares worth over $81k - Investing.com

Click here to get full coverage on P3 Health Partners Names Dr. Aric Coffman as CEO - Business Wire

P3 Health Partners Names Dr. Aric Coffman as CEO  Business Wire

P3 Health Partners Names Dr. Aric Coffman as CEO - Business Wire

Click here to get full coverage on Round-Trip Oxidative Addition, Ligand Metathesis, and Reductive Elimination in a PIII/PV Synthetic Cycle - ACS Publications

Round-Trip Oxidative Addition, Ligand Metathesis, and Reductive Elimination in a PIII/PV Synthetic Cycle  ACS Publications

Round-Trip Oxidative Addition, Ligand Metathesis, and Reductive Elimination in a PIII/PV Synthetic Cycle - ACS Publications

Click here to get full coverage on P3 Health Partners Inc. Announces Approximately $90 Million Private Placement - Business Wire

P3 Health Partners Inc. Announces Approximately $90 Million Private Placement  Business Wire

P3 Health Partners Inc. Announces Approximately $90 Million Private Placement - Business Wire

Click here to get full coverage on Well-Defined PIII-Terminated Polymers from Phosphorylated Carbodithioate RAFT Agents - ACS Publications

Well-Defined PIII-Terminated Polymers from Phosphorylated Carbodithioate RAFT Agents  ACS Publications

Well-Defined PIII-Terminated Polymers from Phosphorylated Carbodithioate RAFT Agents - ACS Publications

Click here to get full coverage on PIII‐Directed Late‐Stage Ligation and Macrocyclization of Peptides with Olefins by Rhodium Catalysis - Wiley Online Library

PIII‐Directed Late‐Stage Ligation and Macrocyclization of Peptides with Olefins by Rhodium Catalysis  Wiley Online Library

PIII‐Directed Late‐Stage Ligation and Macrocyclization of Peptides with Olefins by Rhodium Catalysis - Wiley Online Library

Click here to get full coverage on District of Delaware Holds that ANDA Filer’s Convers... - Dechert

District of Delaware Holds that ANDA Filer’s Convers...  Dechert

District of Delaware Holds that ANDA Filer’s Convers... - Dechert

Click here to get full coverage on An Improved PIII/PV═O-Catalyzed Reductive C–N Coupling of Nitroaromatics and Boronic Acids by Mechanistic Differentiation of Rate- and Product-Determining Steps - ACS Publications

An Improved PIII/PV═O-Catalyzed Reductive C–N Coupling of Nitroaromatics and Boronic Acids by Mechanistic Differentiation of Rate- and Product-Determining Steps  ACS Publications

An Improved PIII/PV═O-Catalyzed Reductive C–N Coupling of Nitroaromatics and Boronic Acids by Mechanistic Differentiation of Rate- and Product-Determining Steps - ACS Publications

Click here to get full coverage on Biphilic Organophosphorus Catalysis: Regioselective Reductive Transposition of Allylic Bromides via P - ACS Publications

Biphilic Organophosphorus Catalysis: Regioselective Reductive Transposition of Allylic Bromides via P  ACS Publications

Biphilic Organophosphorus Catalysis: Regioselective Reductive Transposition of Allylic Bromides via P - ACS Publications

Click here to get full coverage on PIII/PV-Catalyzed Beckmann Reaction and Sequential [2,3]-Sigmatropic Rearrangement to Construct 2-Amidopyridines - ACS Publications

PIII/PV-Catalyzed Beckmann Reaction and Sequential [2,3]-Sigmatropic Rearrangement to Construct 2-Amidopyridines  ACS Publications

PIII/PV-Catalyzed Beckmann Reaction and Sequential [2,3]-Sigmatropic Rearrangement to Construct 2-Amidopyridines - ACS Publications

Click here to get full coverage on Ruthenium-Catalyzed PIII-Directed Remote ε-C–H Alkylation of Phosphines | Organic Letters - ACS Publications

Ruthenium-Catalyzed PIII-Directed Remote ε-C–H Alkylation of Phosphines | Organic Letters  ACS Publications

Ruthenium-Catalyzed PIII-Directed Remote ε-C–H Alkylation of Phosphines | Organic Letters - ACS Publications

Click here to get full coverage on Cycle: Mechanistic Study and Guidelines to Obtain a Good Catalyst - ACS Publications

Cycle: Mechanistic Study and Guidelines to Obtain a Good Catalyst  ACS Publications

Cycle: Mechanistic Study and Guidelines to Obtain a Good Catalyst - ACS Publications

Click here to get full coverage on Intra-domain phage display (ID-PhD) of peptides and protein mini-domains censored from canonical pIII phage display - Frontiers

Intra-domain phage display (ID-PhD) of peptides and protein mini-domains censored from canonical pIII phage display  Frontiers

Intra-domain phage display (ID-PhD) of peptides and protein mini-domains censored from canonical pIII phage display - Frontiers

Click here to get full coverage on P3 Health Partners Closes Business Combination with - GlobeNewswire

P3 Health Partners Closes Business Combination with  GlobeNewswire

P3 Health Partners Closes Business Combination with - GlobeNewswire

Click here to get full coverage on Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial - The Lancet

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial  The Lancet

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial - The Lancet

P3 Health Partners Inc (PIII)

Price Chart

Key Statistics

Technicals

About PIII

Latest News

Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now - Nasdaq

P3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance

P3 Health Partners Inc. (PIII) reports earnings - Quartz

Advanced Charts

Top Gainers

Top Losers